Unlicensed Intravenous Form Of Relenza Helped Save Life Of Swine-Flu Infected Woman Who Had Just Had Chemotherapy

A 22-year-old woman, whose immune system was impaired due to recent chemotherapy, has survived a serious case of swine-flu after being treated with the unlicensed intravenous form of relenza, in combination with high-dose corticosteroids.